|
Volumn 11, Issue 23, 2003, Pages 5051-5058
|
Design, synthesis and evaluation of a series of novel fumagillin analogues
a
Gilead
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
(2 DIMETHYLAMINOETHYL)CARBAMIC ACID 4 (1 BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
3 (1 BENZYLOXYIMINOETHYL) 4 CHLOROMETHYL 4 HYDROXY 2 METHOXYCYCLOHEXANONE;
3 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID 3 (1 BENZYLOXYIMINOETHYL) 4 CHLOROMETHYL 4 HYDROXY 2 METHOXYCYCLOHEXYL ESTER;
3 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID 4 (1 BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
3 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID 4 (1,5 DIMETHYLHEXA 1,4 DIENYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
3 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID 4 CHLOROMETHYL 3 (1,5 DIMETHYLHEXA 1,4 DIENYL) 4 HYDROXY 2 METHOXYCYCLOHEXYL ESTER;
3 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID 4 CHLOROMETHYL 4 HYDROXY 2 METHOXY 3 [2 METHYL 3 (3 METHYLBUT 2 ENYL)OXIRANYL]CYCLOHEXYL ESTER;
3 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID 5 METHOXY 4 [2 METHYL 3 (3 METHYLBUT 2 ENYL)OXYRANYL] 1 OXASPIRO[2.5]OCT 6 YL ESTER;
4 (1 BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCTAN 6 ONE;
4 BENZYLPIPERAZINE 1 CARBOXYLIC ACID 4 (1 BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
4 CHLOROMETHYL 4 HYDROXY 2 METHOXY 3 [2 METHYL 3 (3 METHYLBUT 2 ENYL)OXIRANYL]CYCLOHEXANONE;
4 ETHYLPIPERAZINE 1 CARBOXYLIC ACID 4 (1 BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
4 METHYLPIPERADINE 1 CARBOXYLIC ACID 4 (BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
4 METHYLPIPERAZINE 1 CARBOXYLIC ACID 4 (1 BENZYLOXYIMINOETHYL) 5 METHOXY 1 OXASPIRO[2.5]OCT 6 YL ESTER;
5 METHOXY 4 [2 METHYL 3 (3 METHYLBUT 2 ENYL)OXIRANYL] 1 OXASPIRO[2.5]OCTAN 6 ONE;
5 METHOXY 4 [2 METHYL 3 (3 METHYLBUT 2 ENYL)OXIRANYL] 1 OXASPIRO[2.5]OCTAN 6 ONE OXIME;
ANGIOGENESIS INHIBITOR;
FUMAGILLIN DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CELL PROLIFERATION;
CONTROLLED STUDY;
CRYSTALLOGRAPHY;
DRUG BINDING SITE;
DRUG DESIGN;
DRUG INHIBITION;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
ENDOTHELIUM CELL;
ENZYME ACTIVITY;
HUMAN;
HUMAN CELL;
SUBSTITUTION REACTION;
UMBILICAL VEIN;
|
EID: 0242266514
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2003.08.031 Document Type: Article |
Times cited : (25)
|
References (22)
|